According to KOBAYASHI Pharmaceutical's latest financial reports the company's current EPS (TTM) is $2.70. In 2022 the company made an earnings per share (EPS) of $2.74 a decrease over its 2021 EPS that were of $3.20.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $2.57 | -6.11% |
2022 | $2.74 | -14.37% |
2021 | $3.20 | -2.84% |
2020 | $3.30 | 3.31% |
2019 | $3.19 | 8.9% |
2018 | $2.93 | 14.92% |
2017 | $2.55 | |
2015 | $2.05 | 2.28% |
2014 | $2.01 | 7.77% |
2013 | $1.86 | -36.68% |
2012 | $2.94 | 49.88% |
2011 | $1.96 | -6.4% |
2010 | $2.10 | 23.13% |
2009 | $1.70 |